Clinical trial
ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease - A Randomized Prospective Trial (RIO-Trial)
NCT00156611 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease - A Randomized Prospective Trial (RIO-Trial)
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 2002
- Completion date
- December 31, 2009
- Enrollment
- 420
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.